Core Points - New Ning Logistics is facing a countdown for investor compensation claims due to false statements, with only about two months left for the statute of limitations [1] - The law firm is currently accepting additional claims from investors who purchased New Ning Logistics stock between April 25, 2019, and December 31, 2022 [2] - Long Pharmaceutical Holdings has had successful compensation claims, with ongoing cases and a recent judgment in favor of investors [2] - Long Pharmaceutical Holdings reported significant financial issues, including fund occupation amounting to 179.66 million, which is 92.08% of its latest audited net assets [3] Summary by Category New Ning Logistics - The company has been implicated in a lawsuit for false statements, with a total of 105,120,500.89 yuan in inflated revenue reported for 2018, representing 10.06% of its annual revenue [1] - Investors who bought shares between April 25, 2019, and December 31, 2022, are eligible to file claims [2] Long Pharmaceutical Holdings - The company has had successful investor compensation cases, with amounts of 622,700 yuan and 316,900 yuan involved in ongoing litigation [2] - A risk warning was issued regarding potential financial issues, including fund occupation and irregular guarantees, with an audit report highlighting significant uncertainties [4] - Investors who purchased shares between March 30, 2019, and April 30, 2024, can still initiate claims [4] Financial Issues - Long Pharmaceutical Holdings has identified fund occupation issues totaling 179,662,019.54 yuan, which is a significant portion of its net assets [3]
新宁物流股民索赔案倒计时两个月,长药控股索赔案已有胜诉先例